Annie Van Broekhoven

Title: Innovations by Annie Van Broekhoven

Introduction

Annie Van Broekhoven is a notable inventor based in Berchem, Belgium. She has made significant contributions to the field of recombinant protein expression, particularly in relation to hepatitis C virus (HCV) envelope proteins. With a total of two patents to her name, her work has implications for both diagnosis and treatment of HCV infections.

Latest Patents

Annie's latest patents include "Constructs and methods for expression of recombinant HCV envelope proteins." This invention focuses on vectors and methods for the efficient expression of HCV envelope proteins in eukaryotic cells. The vectors she developed comprise the coding sequence for an avian lysozyme signal peptide, which is effectively removed during the expression process. Another significant patent is "Expression of core-glycosylated HCV envelope proteins in yeast." This invention relates to the use of yeast strains for the efficient expression and purification of core-glycosylated HCV envelope proteins, which can be utilized in various applications, including diagnosis and therapy for HCV infections.

Career Highlights

Annie Van Broekhoven is associated with Innogenetics N.V., a company known for its innovative approaches in the field of biotechnology. Her work has been instrumental in advancing the understanding and treatment of HCV, showcasing her expertise in recombinant protein technologies.

Collaborations

Annie has collaborated with notable colleagues such as Fons Bosman and Erik Depla. These collaborations have further enriched her research and contributed to the successful development of her patents.

Conclusion

Annie Van Broekhoven's contributions to the field of biotechnology, particularly in the area of HCV envelope proteins, highlight her innovative spirit and dedication to advancing medical science. Her patents reflect her commitment to improving diagnosis and treatment options for HCV infections.